Similarly, in thyroid cancer, METTL3-regulated m6A modification enhances STTEAP1 mRNA stability in a YTHDF2-dependent manner, thereby inhibiting thyroid cancer cell proliferation, migration, and invasion [102]. Here, YTHDF2 is linked to thyroid gland carcinoma.